CIRRX | IARAX | CIRRX / IARAX | |
Total Expense Ratio | 1.25 | 1.38 | 91% |
Annual Report Gross Expense Ratio | 1.25 | 1.38 | 91% |
Fund Existence | 11 years | 29 years | - |
Gain YTD | 4.188 | 0.707 | 592% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.35B | 694M | 1,204% |
Annual Yield % from dividends | 2.37 | 1.92 | 123% |
Returns for 1 year | -2.00 | -6.35 | 32% |
Returns for 3 years | 32.19 | 6.29 | 512% |
Returns for 5 years | 26.81 | -0.82 | -3,261% |
Returns for 10 years | 54.80 | -25.77 | -213% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NECCX | 14.82 | 0.02 | +0.14% |
Natixis US Equity Opportunities C | |||
JFNSX | 70.08 | N/A | N/A |
Janus Henderson Global Life Sciences S | |||
VMCPX | 396.31 | N/A | N/A |
Vanguard Mid Cap Index InstitutionalPlus | |||
BGLAX | 14.91 | N/A | N/A |
Brookfield Global Listed InfrastructureA | |||
BRWRX | 27.40 | N/A | N/A |
MFS Blended Research Growth Eq R1 |